Skip to content

MLTXMOONLAKE IMMUNOTHERAPEUTICS

CUSIP 61559X104 · common stock

2 tracked investors held MOONLAKE IMMUNOTHERAPEUTICS (MLTX) at the end of Q3 2026, worth $6.1M in total. The largest holder was Stanley Druckenmiller, with 0.1% of its portfolio. Stanley Druckenmiller opened a new position this quarter.

Holders · Q3 2026
2
New holders
1
Value held
$6.1M
Quarter-end price (est.)
$11.70

Investors holding MLTX · Q3 2026

InvestorWeightSharesValueChange
Stanley Druckenmiller
Duquesne Family Office LLC
0.13%494,000$5.8MNEW
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.01%27,000$315.9KHOLD

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026210$6.1M$11.70
Q2 2026100$525.7K$19.47
Q1 2026110$8.5M$18.64